Severe Uncontrolled Asthma: A Multidisciplinary Approach to Diagnosis, Co-Management, and Advanced Therapies

Program Goals

Asthma is a global health problem that affects approximately 300 million people in all age and ethnic groups. There is an estimated 250,000 deaths each year related to or resulting from Asthma. Treatment guidelines can be difficult to interpret, and it is often challenging for providers to keep abreast of new therapies and updates in guidelines. This program aims to improve physician knowledge about emerging therapies and treatments on severe uncontrolled asthma.

Target Audience

Primary Care Physicians, Pulmonologists, Physician Assistants, Nurses, Nurse Practitioners, Healthcare Administrators, Allied Health Professionals

Learning Objectives

After completion of this activity, participants should be able to:

  1. Define severe persistent asthma.
  2. Apply methodologies used in the work-up and co-management of severe persistent asthma. This includes to co-manage with Allergy/Immunology, GI, and Otolaryngology when appropriate.
  3. Suggest strategies and recommendations in allergen avoidance.
  4. Describe phenotyping and how it impacts the treatment of severe persistent asthma.
  5. Discuss and utilize precision medicine (biologics/immunotherapy) in severe asthma based on results of phenotyping.
  6. Define and discuss bronchial thermoplasty.
  7. Appropriately refer patients with challenging clinical situations to specialty asthma centers for bronchial thermoplasty versus immunotherapy.
  8. Describe COVID-19 and asthma.
  9. Apply strategies for dealing with issues related to GERD and Asthma.
  10. Address ENT related Asthma clinical issues.

Course Directors

Kartik Shenoy, MD
Associate Professor
Department of Thoracic Medicine and Surgery
Lewis Katz School of Medicine at Temple University

Gustavo Adolfo Fernandez Romero, MD
Assistant Professor
Department of Thoracic Medicine and Surgery
Lewis Katz School of Medicine at Temple University

Faculty

  • Sean Duffy, MD, Assistant Professor, Thoracic Medicine and Surgery, LKSOM at Temple University
  • Mark Malamood, MD, Associate Professor of Clinical Medicine, LKSOM at Temple University
  • Caitlin McLean, MD, Assistant Professor, Otolaryngology - Head & Neck Surgery, LKSOM at Temple University
  • Michael Prematta, MD, Adult and Pediatric Allergy and Asthma, Havertown Allergy

Educational Activity Agenda

Front Matter and Registration (3 minutes)
Educational Presentation (2 hours and 23 minutes)
Post Test and Evaluation (15 minutes) 

  • Activity Introduction:  Kartik Shenoy MD
  • Asthma Overview: Kartik Shenoy MD
  • Asthma: Guideline-Based Therapy: Sean Duffy MD
  • Asthma and Allergies: Michael Prematta MD
  • Asthma Mimickers: Kartik Shenoy MD
  • COVID-19 and Asthma: Gustavo Fernandez MD
  • GERD in Asthma Diagnosis and Treatment Options: Mark Malamood MD
  • Surgical vs. Medical Treatment for Chronic Rhinosinusitis:  How to Feel Better (and Stay Better) Faster:  Caitlin McLean MD
  • Treatment Options for Severe Persistent Asthma: Kartik Shenoy MD

Release and Expiration Dates

Release Date: 1/15/2021
Expiration Date: 1/15/2023

Faculty Disclosures

It is the policy of the Lewis Katz School of Medicine at Temple University, the Albert J. Finestone, MD, Office for Continuing Medical Education to insure balance, independence, objectivity, and scientific rigor in all its individually sponsored educational programs.  All faculty, program planning committee members, and Lewis Katz School of Medicine at Temple University Continuing Medical Education staff participating in any Temple University sponsored programs are expected to disclose to the program audience ANY real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program.  This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.  The Accreditation Council for Continuing Medical Education (ACCME) considers financial relationships to create actual conflicts of interest in CME when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest. The ACCME defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.” The ACCME does not consider providers of clinical service directly to patients to be commercial interests.  All conflicts of interest identified have been resolved utilizing the Lewis Katz School of Medicine at Temple University conflict of interest policies and procedures in adherence with ACCME (Accreditation Council for Continuing Medical Education) guidelines.

Kartik Shenoy, MD

  • Consultant: AstraZeneca

Sean Duffy, MD

  • Consultant: Merck

Michael Prematta, MD

  • Speaker' Bureau: Boehringer Ingelheim, AstraZeneca, GSK

Gustavo Adolfo Fernandez Romero, MD

  • Nothing to Disclose

Mark Malamood, MD

  • Nothing to Disclose

Caitlin McLean, MD

  • Nothing to Disclose

Planners and Managers Disclosures

The planners and managers reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Thomas Broderic

  • Nothing to disclose

Susan Estrella-Eades, MSN, CRNP, FNP-BC

  • Consultant: AstraZeneca; Boehringer Ingelheim
  • Speakers’ Bureau: AstraZeneca; Sanofi Genzyme

Arnold I. Meyer, Ed.D, FACEHP

  • Nothing to disclose

Katrina Ilagan

  • Nothing to disclose

Saqib Rehman, MD, MBA (Reviewer)

  • Nothing to disclose

Accreditation Statement

Lewis Katz School of Medicine at Temple University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians.

Certification Statement

Lewis Katz School of Medicine at Temple University designates this enduring material for a maximum of 2.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

It is the policy of the Lewis Katz School of Medicine at Temple University, The Albert J. Finestone, M.D, Office of Continuing Medical Education that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Accreditation Council for Continuing Medical Education (ACCME) considers financial relationships to create actual conflicts of interest in CME when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest. The ACCME defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.” The ACCME does not consider providers of clinical service directly to patients to be commercial interests. The Lewis Katz School of Medicine at Temple University has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.  Detailed disclosure will be made prior to the activity.

How to Obtain CME Credit

Attendees are expected to view all presentations before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credit(s)™.  To receive credit, the course must be completed between January 15, 2021 – January 15, 2023.

Participation in this activity should be completed in approximately 2.75 hours. Please follow these steps in order to receive CME/CE credit for viewing the webcast:

  • Read all of the CME/CE accreditation information above.
  • View the complete electronic (web) activity.
  • Click on the link to apply for CME/CE credits.
  • Complete the online registration (registration is free).
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate.

After successfully completing the online test and/or evaluation, your application will be immediately processed, and you will be given the opportunity to download a personalized CME/CE certificate for participation in this activity.

Should you have any CME questions regarding this activity, please contact:
The Albert J. Finestone, MD Office for Continuing Medical Education
Lewis Katz School of Medicine at Temple University
3440 North Broad Street
Philadelphia, PA  19140
Main CME Phone:  215-707-4787
Fax:  215-707-8268

Commercial Support Statement

This activity is supported by an educational grant from AstraZeneca.

System Requirements

To view this educational activity you, will need a web browser with Javascript and either Flash or HTML5 enabled. Nearly all modern web browsers will work.


 

TADA Image If you have special accommodations that we can address to make your participation more meaningful and enjoyable, please contact our office at (215) 707-4787 or cme@temple.edu.

Copyright

Copyright © 2021. Temple University. Philadelphia, PA. All rights reserved.


Published

January 15, 2021

Expires

January 15, 2023

Related Presenters

Kartik V. Shenoy, MD

Kartik V. Shenoy, MD

Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

Sean P. Duffy, MD

Sean P. Duffy, MD

Assistant Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

Gustavo Adolfo Fernandez Romero, MD

Gustavo Adolfo Fernandez Romero, MD

Assistant Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University